Company · Ownership research

ACADIA PHARMACEUTICALS INC ACAD

CIK 0001070494

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 93 rows; the complete set is available through the API.

Insider filings on file run through Oct 30, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $0.00
Sold: $8.23M

Nov 1, 2023 – Oct 30, 2026
Available records · partial months are marked ·

202410 of 25 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 19, 2024	Teehan Brendan EVP, COO, HEAD OF COMMERCIAL	Sale10b5-1 footnote	$173.63K 10,329 shares sold	14.26% sold Direct holding	▾
Nov 19, 2024	Kihara James PRINCIPAL ACCOUNTING OFFICER	Sale10b5-1 footnote	$68.47K 4,073 shares sold	17.02% sold Direct holding	▾
Nov 19, 2024	Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER	Sale10b5-1 footnote	$172.45K 10,259 shares sold	16.14% sold Direct holding	▾
Aug 19, 2024	Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER	Sale10b5-1 footnote	$148.72K 9,733 shares sold	18.20% sold Direct holding	▾
Aug 19, 2024	Teehan Brendan EVP, COO, HEAD OF COMMERCIAL	Sale10b5-1 footnote	$145.68K 9,534 shares sold	15.45% sold Direct holding	▾
Aug 19, 2024	DAVIS STEPHEN CEO · Director	Sale10b5-1 footnote	$485.09K 31,747 shares sold	14.54% sold Direct holding	▾
Jun 10, 2024	Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER	Sale10b5-1 footnote	$14.42K 975 shares sold	2.74% sold Direct holding	▾
May 2, 2024	Teehan Brendan EVP, COO, HEAD OF COMMERCIAL	Sale10b5-1 footnote	$58.90K 3,477 shares sold	7.62% sold Direct holding	▾
May 2, 2024	DAVIS STEPHEN CEO · Director	Sale10b5-1 footnote	$193.57K 11,427 shares sold	6.86% sold Direct holding	▾
May 2, 2024	Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER	Sale10b5-1 footnote	$59.34K 3,503 shares sold	9.85% sold Direct holding	▾

Showing 25 / 25 record groups in 2024. The complete set is available through the API.

ACADIA PHARMACEUTICALS INC · ACAD

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 25 of 25 purchase / sale groups and 30 of 93 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"ACAD","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.